0.75 semaglutide Wegovy (semaglutide) Injector 1.7 mg/0.75 mL, 4 Pens Per Box **Refrigerated Item** which helps to increase the feeling of fullness and reduce appetite Wegovy 2.4 mg/0.75 mL pre-filled

Unii-53axn4nnhx 9

There are even fewer studies supporting the effect of other types of DPP-4 in NAFLD: in a double-blind RCT involving 44 patients with well-controlled T2DM vildagliptin was proven to reduce liver trygliceride content assessed by MRI along with achieving a significant improvement in serum transaminase and fasting plasma glucose after a 6-month course

The median number of outpatient visits within 180 days after the initiation of oral semaglutide maintenance dose was two, defined as the 1st visit and 2nd visit. Additionally, the first outpatient visit occurring after the 180-day period following the initiation of the maintenance dose was defined as the first visit after 180 days. These visits were used to monitor clinical parameters, including HbA1c and body weight, with follow-up continued until the first visit after 180 days

Measurement bias was estimated as the differences between standardized emotional well-being scores from a 1-class model (assuming no heterogeneity) and a k-class model (accommodating heterogeneity)